↓ Skip to main content

Statin drugs to reduce breast cancer recurrence and mortality

Overview of attention for article published in Breast Cancer Research, November 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
4 news outlets
blogs
2 blogs
twitter
3 X users
patent
1 patent

Citations

dimensions_citation
138 Dimensions

Readers on

mendeley
128 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Statin drugs to reduce breast cancer recurrence and mortality
Published in
Breast Cancer Research, November 2018
DOI 10.1186/s13058-018-1066-z
Pubmed ID
Authors

Colin H. Beckwitt, Adam Brufsky, Zoltán N. Oltvai, Alan Wells

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 128 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 11%
Student > Master 14 11%
Student > Ph. D. Student 10 8%
Student > Doctoral Student 10 8%
Student > Bachelor 9 7%
Other 18 14%
Unknown 53 41%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 16%
Medicine and Dentistry 17 13%
Agricultural and Biological Sciences 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Nursing and Health Professions 4 3%
Other 10 8%
Unknown 61 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 54. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2023.
All research outputs
#782,847
of 25,394,764 outputs
Outputs from Breast Cancer Research
#60
of 2,054 outputs
Outputs of similar age
#17,478
of 446,267 outputs
Outputs of similar age from Breast Cancer Research
#3
of 34 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,267 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.